Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study

Por Lasson, Anders, Öhman, Lena, Stotzer, Per-Ove, Isaksson, Stefan, Überbacher, Otto, Ung, Kjell-Arne, Strid, Hans
Publicado no United European Gastroenterol J (2015)

CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis

Por Magnusson, Maria K, Dahlén, Rahil, Strid, Hans, Isaksson, Stefan, Simrén, Magnus, Lasson, Anders, Bajor, Antal, Ung, Kjell-Arne, Öhman, Lena
Publicado em 2013